Doing Well, While Doing Good

Marathon is a distinguished healthcare partner offering strategic Corporate Lending & Asset-Based solutions to biopharma, diagnostic, medical device, and service-oriented companies.

Marathon has invested over $10 billion in capital for healthcare, covering both public and private debt, royalties, and equity.

Our competitive edge stems from our team's rigorous scientific analysis and financial underwriting across:






Medical Devices




Managed Care


Hospital Systems


Invested in the Healthcare Industry


Patients Addressed Globally by Companies that Marathon Financed

25+ Years

Of Average Experience for Healthcare Finance

Marathon has been committed to advancing patient health, while adhering to our guiding principle of "Doing Well, While Doing Good," through the delivery of customized solutions for our partners.

Marathon is comprised of a diverse group of experts, including:

  • Dedicated Investment Professionals
  • Healthcare Bankers
  • PhDs and MDs
  • 6 Renowned Leaders on
    Medical Advisory Board
  • Consultants
  • In-House Legal & Structuring Experts

Marathon works collaboratively in striving to achieve optimal outcomes for our partners. Our expertise in navigating numerous market cycles and our ability to identify, price, and structure investments allow us to make thoughtful decisions across the capital structure. We strive to consistently deliver exceptional performance through superior sourcing, rigorous medical research, fundamental financial analysis, execution, and robust internal asset management.

video image


 Asset-Based Lending & Royalty Monetization

Provide Secured Asset-Based Loans & Royalty Solutions

  • Asset-Based Secured Loans
  • Royalty Acquisitions
  • Synthetic Royalty

Direct Lending & Capital Solutions

Provide Bespoke Corporate Loans and Creative Partnership Capital

  • Senior Loans
  • Mezzanine Debt
  • Convertible Debt
  • Preferred Equity
  • Customized Capital Solutions

Select Marathon

Marathon is focused on providing creative corporate and asset-based capital to healthcare companies to fund product launches, acquire assets, license products, or re-invest capital in earlier-stage R&D Projects.

  • Kaleo Pharmaceuticals
  • Dermavant
  • Healogics
  • ATI Physical Therapy
  • Team Health
  • Kynmobi

Investment Vehicles

  • Closed-End Funds
  • Fund of One & Separately Managed Account

Marathon's world-class and exclusive Medical Advisory Board of 6 renowned thought-leaders are active across premier academic institutions, biopharma and pharmaceutical companies.

Marathon's Healthcare Team has a successful history of partnering with inventors, educational institutions, hospitals, universities, and pharmaceutical companies. Under the leadership of Dr. Evan Bedil, Marathon's 15-person team includes 9 in-house healthcare professionals in the U.S. and Europe with diverse skills including scientific, clinical, commercial, financial, operational, and legal expertise.

Contact Us

To contact Marathon's Healthcare Finance team, please reach out to one of the key contacts below:

For Healthcare Finance Transactions:

Dr. Evan Bedil
Managing Director - Healthcare Finance

For Investors:

Jason Friedman
Partner - Global Head of Strategy and
Business Development or